This statistic shows the distribution of incrementally modified drugs approved in South Korea from 2009 to 2016, by type. During this time period, osteoporosis drugs accounted for 19.5 percent of the total incrementally modified drugs approved in South Korea.
Distribution of incrementally modified drugs approved in South Korea from 2009 to 2016, by type
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$69 USD $49 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you
Population
8
- Basic Statistic Total population of South Korea 2028
- Basic Statistic Population growth in South Korea 2021
- Premium Statistic Number of births in South Korea 2000-2021
- Basic Statistic Crude birth rate in South Korea 2011-2021
- Basic Statistic Life expectancy at birth in South Korea 2021
- Basic Statistic Age distribution in South Korea 2021
- Basic Statistic Median age of the population in South Korea 2020
- Premium Statistic Total death rate of South Korea 2000-2021
Economy
8
- Basic Statistic Gross domestic product (GDP) in South Korea 2028
- Basic Statistic Gross domestic product (GDP) growth in South Korea 2028
- Basic Statistic Distribution of gross domestic product (GDP) across economic sectors South Korea 2021
- Basic Statistic Employment by economic sector in South Korea 2021
- Basic Statistic Employment in South Korea 2024
- Basic Statistic Unemployment rate in South Korea 2028
- Basic Statistic Inflation rate in South Korea 2028
- Premium Statistic Export of goods from South Korea 2021
National finances
5
- Premium Statistic National debt of South Korea 2028
- Basic Statistic National debt of South Korea in relation to gross domestic product (GDP) 2028
- Basic Statistic Ratio of military expenditure to gross domestic product (GDP) in South Korea 2021
- Basic Statistic Ratio of government expenditure to gross domestic product (GDP) in South Korea 2028
- Basic Statistic South Korea's budget balance in relation to GDP 2028
The two Koreas
8
- Premium Statistic South Korea's export to North Korea 2005-2021
- Premium Statistic South Korea's export to North Korea 2005-2021
- Premium Statistic South Korea's import from North Korea 2005-2018
- Premium Statistic South Korea's import value from North Korea 2005-2021
- Premium Statistic South Korea's trade balance with North Korea 2005-2021
- Premium Statistic South Korea's GDP growth rate compared to North Korea 1990-2021
- Basic Statistic Satisfaction with the policy toward North Korea in South Korea 2007-2016
- Basic Statistic Attitudes toward North Korea in South Korea 2007-2021
South Korea and the coronavirus
5
- Basic Statistic COVID-19 cases worldwide as of May 2, 2023, by country or territory
- Basic Statistic New cases of COVID-19 worldwide from January 23, 2020 to April 25, 2023, by day
- Basic Statistic Cumulative cases of COVID-19 worldwide from Jan. 22, 2020 to Apr. 25, 2023, by day
- Basic Statistic COVID-19 deaths worldwide as of May 2, 2023, by country and territory
- Basic Statistic Coronavirus (COVID-19) cases, recoveries, and deaths worldwide as of May 2, 2023
Further related statistics
17
- Osteoporosis drug market size in China 2008-2016
- Number of medicines in development for heart disease and stroke by type 2018
- Anti-osteoporosis and calcium supplementation drugs market size China 2008-2016
- Reasons why clinical trial organizations use direct-to-patient distribution 2016
- Market share of anti-osteoporosis drugs in public medical institutions China 2016
- Anti-osteoporosis drugs retail sales market share China 2015
- Number of NAS approved by Health Canada 2014-2020
- Bisphosphonate market size in China 2007-2016
- Annual cost of MS drugs by select countries 2013-2014
- Calcitriol market size in China 2007-2016
- Osteoporosis drugs estimated market size in South Korea 2014-2020
- Top indications for new brand drug approvals in Canada in 2018
- Novel biologics in development worldwide in 2017, by indication
- U.S. pain medication clinical pipeline in 2017, by phase and indication
- Revenue of AFC Bournemouth by segment in 2016/17 and 2018/19
- Geographical distribution of smartwatch companies in 2013, by country
- Licensed car distribution across the regions of Great Britain (UK) 2017
Further Content: You might find this interesting as well
Statistics
- Osteoporosis drug market size in China 2008-2016
- Number of medicines in development for heart disease and stroke by type 2018
- Anti-osteoporosis and calcium supplementation drugs market size China 2008-2016
- Reasons why clinical trial organizations use direct-to-patient distribution 2016
- Market share of anti-osteoporosis drugs in public medical institutions China 2016
- Anti-osteoporosis drugs retail sales market share China 2015
- Number of NAS approved by Health Canada 2014-2020
- Bisphosphonate market size in China 2007-2016
- Annual cost of MS drugs by select countries 2013-2014
- Calcitriol market size in China 2007-2016
- Osteoporosis drugs estimated market size in South Korea 2014-2020
- Top indications for new brand drug approvals in Canada in 2018
- Novel biologics in development worldwide in 2017, by indication
- U.S. pain medication clinical pipeline in 2017, by phase and indication
- Revenue of AFC Bournemouth by segment in 2016/17 and 2018/19
- Geographical distribution of smartwatch companies in 2013, by country
- Licensed car distribution across the regions of Great Britain (UK) 2017
Samsung Securities. (August 25, 2017). Distribution of incrementally modified drugs approved in South Korea from 2009 to 2016, by type [Graph]. In Statista. Retrieved June 01, 2023, from https://www.statista.com/statistics/770870/south-korea-approvals-of-incrementally-modified-drugs-by-type/
Samsung Securities. "Distribution of incrementally modified drugs approved in South Korea from 2009 to 2016, by type." Chart. August 25, 2017. Statista. Accessed June 01, 2023. https://www.statista.com/statistics/770870/south-korea-approvals-of-incrementally-modified-drugs-by-type/
Samsung Securities. (2017). Distribution of incrementally modified drugs approved in South Korea from 2009 to 2016, by type. Statista. Statista Inc.. Accessed: June 01, 2023. https://www.statista.com/statistics/770870/south-korea-approvals-of-incrementally-modified-drugs-by-type/
Samsung Securities. "Distribution of Incrementally Modified Drugs Approved in South Korea from 2009 to 2016, by Type." Statista, Statista Inc., 25 Aug 2017, https://www.statista.com/statistics/770870/south-korea-approvals-of-incrementally-modified-drugs-by-type/
Samsung Securities, Distribution of incrementally modified drugs approved in South Korea from 2009 to 2016, by type Statista, https://www.statista.com/statistics/770870/south-korea-approvals-of-incrementally-modified-drugs-by-type/ (last visited June 01, 2023)
Distribution of incrementally modified drugs approved in South Korea from 2009 to 2016, by type [Graph], Samsung Securities, August 25, 2017. [Online]. Available: https://www.statista.com/statistics/770870/south-korea-approvals-of-incrementally-modified-drugs-by-type/